Y-Intercept »

Biosante Pharmaceuticals shares owned by Y-Intercept

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Y-Intercept from 13F filings

Historical chart of Y-Intercept investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Y-Intercept consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Y-Intercept

Quarter filed Position value Share count Share price at filing
2024-09-30 $405k 6.8k 59.66

More positions owned by Y-Intercept

Meta Platforms Cl A (META)
Lennar Corp Cl A (LEN)
Blackstone Group Inc Com Cl A (BX)
Lockheed Martin Corporation (LMT)
Broadcom (AVGO)
Metropcs Communications (TMUS)
Novo-nordisk A S Adr (NVO)
Consolidated Edison (ED)
Advanced Micro Devices (AMD)
Norfolk Southern (NSC)
MercadoLibre (MELI)
Regeneron Pharmaceuticals (REGN)
Newmont Mining Corporation (NEM)
L3harris Technologies (LHX)
Atlassian Corporation Cl A (TEAM)

View all positions for Y-Intercept

Top funds holding Biosante Pharmaceuticals

BlackRock
Vanguard Group
Millennium Management
State Street Corporation
Goldman Sachs Group
Dimensional Fund Advisors
Global Alpha Capital Management
Citadel Advisors
UBS Group
Ranger Investment Management
Macquarie Group
Deep Track Capital
William Blair Investment Management
Geode Capital Management
Tang Capital Management

View all funds holding Biosante Pharmaceuticals